- The United State has begun the phase one of the clinical Human trial of an investigational vaccine designed to save against the coronavirus disease which has claimed the lives of over 7,000 people globally.
- The trial has been begun at the Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle.